The ETV6 gene encodes an Ets-like transcription factor that is frequently rearranged in leukemias. While some of the functions of ETV6 have been uncovered recently, little is known about the key structural elements involved. Comparative genome analysis may provide novel insights into gene evolution and functions. In this study, we cloned and sequenced the homologue of ETV6 from the compact genome of the puer®sh Fugu rubripes (fETV6). The genomic structure of the fETV6 gene was investigated by sequence analysis of a contig of genomic clones. The fETV6 gene, composed of eight exons, spans about 15 kb and is 16 times smaller than its human counterpart mainly because of the reduced intron size. Three of the seven introns of fETV are unusually large (more than 2 kb), including the 8.2 kb intron 2. The gene codes for a protein of 465 amino acids that is highly related to its human homologue, exhibiting an overall identity of 58% (72% similarity). To investigate the functional and evolutionary aspects of ETV6, we undertook a comparative analysis of this gene from various vertebrates (human, mouse, chicken, zebra®sh and Fugu). As expected, the PNT and ETS domains were highly conserved, with on average 81 and 95% peptide sequence identity, respectively. In addition, we found several new highly conserved regions within the central section of the protein that are likely to represent further functional or structural domains, which may be associated with the transcription repression capacity of this protein. We also found conserved putative regulatory elements in the promoter as well as in the large intron 2 of fETV6. The information derived from this comparative analysis will serve as the basis for more precise functional studies of ETV6 gene regulation and function. Oncogene (2001) 20, 3437 ± 3442.
The ETV6 gene encodes an Ets-like transcription factor that is frequently rearranged in leukemias. While some of the functions of ETV6 have been uncovered recently, little is known about the key structural elements involved. Comparative genome analysis may provide novel insights into gene evolution and functions. In this study, we cloned and sequenced the homologue of ETV6 from the compact genome of the puer®sh Fugu rubripes (fETV6). The genomic structure of the fETV6 gene was investigated by sequence analysis of a contig of genomic clones. The fETV6 gene, composed of eight exons, spans about 15 kb and is 16 times smaller than its human counterpart mainly because of the reduced intron size. Three of the seven introns of fETV are unusually large (more than 2 kb), including the 8.2 kb intron 2. The gene codes for a protein of 465 amino acids that is highly related to its human homologue, exhibiting an overall identity of 58% (72% similarity). To investigate the functional and evolutionary aspects of ETV6, we undertook a comparative analysis of this gene from various vertebrates (human, mouse, chicken, zebra®sh and Fugu). As expected, the PNT and ETS domains were highly conserved, with on average 81 and 95% peptide sequence identity, respectively. In addition, we found several new highly conserved regions within the central section of the protein that are likely to represent further functional or structural domains, which may be associated with the transcription repression capacity of this protein. We also found conserved putative regulatory elements in the promoter as well as in the large intron 2 of fETV6. The information derived from this comparative analysis will serve as the basis for more precise functional studies of ETV6 gene regulation and function. Oncogene (2001) 20, 3437 ± 3442.
Keywords: ETV6; transcription factor; comparative genetics; vertebrate genomes; Fugu rubripes ETV6 (also known as TEL) is a member of the Ets family of DNA-binding proteins. It is composed of eight exons distributed over 240 kb of genomic DNA (Baens et al., 1996) . ETV6 was originally identi®ed as the 5' partner of PDGFRb in a fusion gene created by a t(5;12) translocation found in a subset of chronic myelomonocytic leukemias (Golub et al., 1994) . Subsequently, several translocations involving ETV6 and various partners have been documented in dierent hematological malignancies as well as in congenital ®brosarcoma, most of these leading to the formation of chimeric fusion products (reviewed in Rubnitz et al., 1999) . Many of the resulting fusion proteins have been shown to transform cells in vitro (Carroll et al., 1996; Lacronique et al., 1997; Hannemann et al., 1998; Buijs et al., 2000; Liu et al., 2000; Wai et al., 2000) or to induce hematological malignancies in mice (Tomasson et al., 1999; Schwaller et al., 1998; Carron et al., 2000) Also, allelic loss at the ETV6 locus on the short arm of chromosome 12 has been observed in various cancers (reviewed in Aissani et al., 1999) suggesting that the human ETV6 gene lies within a region frequently altered in cancer cells.
ETV6 is a nuclear phosphoprotein that is widely expressed in all normal tissues and plays an important role in angiogenesis (Wang et al., 1997) as well as in the normal development of the hematopoietic system (Wang et al., 1998) . Like all Ets proteins, ETV6 binds a speci®c DNA sequence consisting of a purine-rich GGAA/T core motif within the promoters of the target genes through the highly conserved ETS domain located at its C-terminus (e.g. Donaldson et al., 1996) . In addition, ETV6 can dimerize through its conserved pointed oligomerization domain (termed PNT domain), located at its Nterminus, with itself or with other partners such as UBC9 , Fli-1, another Ets member (Kwiatkowski et al., 1998) , and TEL2, a protein highly related to ETV6 Poirel et al., 2000) . Contrary to most of the Ets proteins, ETV6 acts as a transcription repressor by recruiting proteins involved in the histone-deacetylase pathway. The domain responsible for this activity is not well characterized but has been located in the large central section of the protein (Lopez et al., 1999; .
Given the extensive involvement of Ets factors in normal hematopoiesis and in hematological malignancies, a complete understanding of these complex processes relies on the characterization of known Ets genes such as ETV6. We propose that the comparative analysis of ETV6 in dierent vertebrate species will lead to the identi®cation of key domains of the protein and regulatory elements that may perform important functions. However, the overall high degree of amino acid identity between the human and mouse proteins precludes the use of this comparison to identify small conserved blocks that could have functional signi®-cance. The teleost ®sh Fugu rubripes has been shown to be a useful model genome for comparative sequence analysis by virtue of its small size (*400 Mb) and its compact gene organization (Brenner et al., 1993) . The greater evolutionary distance between Fugu and human can be exploited to determine functional domains, as these regions are likely to show a higher degree of sequence conservation. Hence, this approach has previously led to the discovery of important functional protein domains (Baxendale et al., 1995; Caldas et al., 1998) .
To identify the Fugu homologue of ETV6, two gridded genomic Fugu libraries, Cosmid library 66, cloned in Lawrist 4 (distributed by RZPD, Berlin, Germany), and a BAC library cloned in pBeloBAC11 (obtained from Genome Systems), were initially screened at low stringency with a radiolabeled cDNA probe corresponding to exons 2 ± 4 of the human ETV6 cDNA (GenBank: NM_001987). This led to the identi®cation of ®ve positive clones: four BACs (220c16, 225j23, 227h21 and 235e13) and one Cosmid (ICRFc66A1236Q1.3). A strongly hybridizing 1 kb EagI fragment was present in all ®ve genomic clones tested. Following the subcloning and sequencing of this restriction fragment, BlastN analysis revealed strong homology to the third exon of the human and mouse ETV6 genes, thus con®rming the identi®cation of the Fugu rubripes homologue (fETV6). Thereafter the entire sequence of the fETV6 gene with its¯anking regions was determined from overlapping genomic clones. The sequence was deposited in GenBank (Accession number AF340230).
The positions and sizes of the coding exons in fETV6 were determined by comparison with the human and zebra®sh gene and by using exon prediction programs to detect splicing donor and acceptor sites (Table 1) . The Fugu and human ETV6 genes showed 63% sequence identity at the nucleotide level (data not shown). They are both composed of eight exons of similar sizes and the positions of the introns are perfectly conserved between the two species ( Figure 1a) . Exons 3 ± 8 were well predicted by all exon prediction programs and clearly corresponded to the human gene structure. Only the FGene program predicted exons 1 and 2 correctly, although it predicted many other false positives. It predicted a 27 bp exon with an in-frame methionine that could be aligned with ETV6 exon 1 from other species and a 130 bp exon that had strong homology to a zebra®sh ETV6 cDNA at the nucleotide level. As predicted, the introns are much smaller in Fugu, ranging from 81 to 8185 bp compared to 1.3 kb to more than 100 kb for the human gene ( Figure 1a , Table 1 ). Consequently, the fETV6 gene (*15 kb long from ATG to Stop codon) is 16 times smaller than its human counterpart (238 kb). In comparison, the Fugu G6PD gene is reduced 3.8-fold whereas the APP gene is compacted 30 times compared to their human counterparts (Mason et al., 1995; Villard et al., 1998) . The degree of compaction most probably depends on the degree of AT-richness of the corresponding human chromosomal location (Villard et al., 1998) . However, in fETV6, the introns 1 (2.1 kb), 2 (8.1 kb) and 3 (2.3 kb) are much larger than the average size of 150 bp reported for the Fugu genome (Elgar et al., 1996) . No major repeated element such as Alu-like and LINE sequences was found in these introns or in the whole fETV6 gene. The only repetitive elements identi®ed were dinucleotide repeats, in the 5' and 3' anking regions as well as in intron 2, and GGA and GGGGA repeats in introns 2 and 3, respectively (data not shown). Thus, this may suggest the presence of additional exons, regulatory sequences or even other genes. Blast analysis of these intronic sequences failed to reveal homology with known proteins or the presence of the putative human alternative exon 1b. Baens et al. (1996) . Intron sizes were calculated from GenBank Accession numbers U81830, U81831, U81832, U81834, AC005989 and NT_000601 forming the ETV6 contig. The exon/intron junctions of fETV6 were deduced by using NIX program (http://www.hgmp.mrc.ac.uk/) which uses several dierent exon prediction programs However, it revealed the presence of a conserved sequence of *80 bp in both the human and the Fugu intron 2 (Figure 1b) . No consensus 5' splice donor site or the presence of wobble bases could be identi®ed in or near the homologous sequence thus ruling out the presence of an exon. Further studies will be required to determine what role this sequence plays in the regulation of the transcription of ETV6, but it illustrates the importance of the Fugu genome as a comparative model. We sequenced approximatively 2.5 kb upstream of the ®rst Fugu exon. The comparison of the promoter region of the Fugu and human ETV6 genes was performed with the TFSEARCH algorithm (http:// pdapl.trc.rwcp.or.jp/research/db/TFSEARCH.html). Of note the transcriptional start has not been determined experimentally in both genes. The Fugu promoter, like its human counterpart, does not seem to contain a TATA box. However, both human and Fugu promoters contain consensus binding sites for GATA, STAT, AML-1, MZF1 and Ets factors (data not shown) that are all known to play a role in hematopoiesis or angiogenesis. In contrast, the human promoter contains numerous Sp1 sites in the 5' upstream region but none could be found in the Fugu promoter, which could re¯ect some dierences in their respective mechanism of transcription.
Further studies will be required to con®rm these preliminary results, but this is consistent with several reports of conserved non-coding sequences, between Fugu and human genes, located in promoters, 3' UTR and even introns How et al., 1996; Kimura et al., 1997; Rowitch et al., 1998; Miles et al., 1998; Gellner and Brenner 1999) . Some of them have been shown to have functional signi®cance in vivo Kimura et al., 1997; Rowitch et al., 1998 ).
An open reading frame could be assembled from the eight predicted exons encoding a protein of 465 amino acids. The predicted fETV6 protein sequence was aligned against the sequence of other vertebrates (zebra®sh, chicken, mouse and human) using ClustalW and manual re®nements (Figure 2) . Being a teleost like Fugu, the zebra®sh sequence was helpful to identify the less-conserved coding regions, furthermore the large evolutionary distance between the two ®shes (in the order of a few hundred Myr) adds weight to the signi®cance of the comparative analysis (e.g. Venkatesh et al., 2000) . A zebra®sh partial ETV6 cDNA was obtained from RZPD (WashU clone fc03a10; RZPD Clone ID MPMGp60911922) and the complete sequence was determined in our laboratory and deposited in GenBank (Accession number AF339838). The overall amino acid sequence identity and similarity Figure 2 Alignment of the predicted ETV6 amino acid sequence from various vertebrates. Human (Swissprot: P41212), mouse (Swissprot: P97360), chicken (partial; GenBank: AAC97200), zebra®sh (GenBank: AF339838) and Fugu (GenBank: AF340230) ETV6 sequences were aligned using the ClustalW algorithm (Thompson et al., 1994) and manually edited using the SeaView program (http://pbil.univ-lyon1.fr/software/seaview.html). Alignments were displayed using the BOXSHADE program (http:// www.ch.embnet.org/software/BOX_form.html). Drosophila PNT and ETS sequences from Yan protein (GenBank: A43315) are shown for comparison. Dashes indicate gaps introduced to maintain optimal alignment. The corresponding exons (numbered from 1 to 8) in the genomic sequence are indicated at the top. BOX A, B, C: regions of strong conservation in the central section (see text). MAPK: consensus phosphorylation site for MAP kinase. Dashed box indicates MAPK putative sites present in human but not conserved across all species studied (see text). Positions in the human protein are indicated on the right between the Fugu and human predicted ETV6 proteins is 58 and 72%, respectively. As expected the highest sequence identity was found in the regions corresponding to the PNT (encoded by exons 3 and 4) and ETS (encoded by exons 6 ± 8) domains. The PNT and ETS domains show sequence identity of 81 and 95% respectively between human and Fugu, and are strongly conserved even in Yan, the Drosophila homologue of ETV6 (Figure 2 ). These domains are crucial for hetero/ homo dimerization and DNA-binding through a conserved purine GGAA motif, respectively (e.g. Donaldson et al., 1996; Slupsky et al., 1998) .
The central section of the protein, represented by the entire exon 5, is less well conserved. However, several domains termed boxes A, B, and C as well as smaller motifs were shown to be shared by all studied species (Figure 2) , suggesting an important function or structural role. These conserved regions would have remained undiscovered if only mouse/human comparisons were performed. We can only speculate about the putative function of these sequences, but it was recently shown that ETV6 acts as a repressor of transcription (Lopez et al., 1999) and that the central domain could mediate this function through the binding of SMRT, mSin3A and NCoR, which are well-known transcriptional repressors . The limits of this putative functional domain were narrowed down to residues 171 ± 285 of the human ETV6 protein (Lopez et al., 1999) that encompasses the conserved boxes A, B and C as well as a putative phosphorylation site.
The activity of several mammalian Ets-like proteins as well as Drosophila Yan and Pointed proteins is regulated by the Ras/MAPK pathway through phosphorylation (reviewed in Wasylyk et al., 1998) . The human ETS-1, ETS-2, and Drosophila Pointed proteins contain a MAPK phosphorylation consensus site (P-X(1-2)-T/S-P) near their pointed domains that are phosphorylated on a conserved threonine (Slupsky et al., 1998; Wasylyk et al., 1998) . ETV6 has been shown to be hyperphosphorylated in vivo . The human ETV6 contains at least three putative consensus phosphorylation sites for MAPK including one located at an equivalent position, upstream of the PNT domain, to the actual MAPK phosphorylation site in ETS-1. It is worth mentioning that it is still unknown whether ETV6 is indeed a target of these protein kinases. By looking at the ETV6 alignment we see clearly that this site is not conserved in Fugu (dotted box in Figure 2 ). However there is another putative MAPK site located in the central section, involving residues 255 ± 258 of the human protein, that is conserved across all species. This phosphorylation site may represent a conserved regulatory mechanism in ETV6 proteins. It is important to note that mutation of the ®rst MAPK site did not alter the function of ETV6 indicating that this site is not important or that another site is present in the protein . Furthermore, a construction resulting in ETV6 initiated at the second in-frame ATG, thus missing the ®rst MAPK site, could still be phosphorylated in transfected Cos cells .
Analysis of the human ETV6 transcript species suggested the presence of splicing variants: one was shown to have skipped exon 2 (Romana et al., 1995) and one that had an alternative exon (termed exon 1b) spliced directly to exon 3 (Baens et al., 1996) . Those two transcripts could only use the third in-frame ATG (position 89 of the human protein) as their translation start to generate full-length proteins, but their functional signi®cance is still unknown. In addition, Poirel et al. (1997) suggested that an ETV6 fastmigrating species (50 vs 57 kDa) was generated by its translation beginning at the second in-frame ATG (pos.57 in human). As mentioned earlier, we were unable to detect a sequence with similarity to the human alternative exon 1b in the corresponding Fugu intron. This could re¯ect the lack of function and thus conservation of this sequence (it is a non-coding exon in human) or indicate a mammalian-speci®c (at least in human) splicing variant. However, the alignment of the ETV6 proteins reveals that the second and the third inframe methionine are well conserved in all species except for zebra®sh, although in this case another methionine is found 13 residues from the expected second methionine (Figure 2 ).
In conclusion, the use of Fugu rubripes, which has one of the smallest genomes of the vertebrates, is an important strategy in the molecular study of gene functions. Because of the large evolutionary distance between Fugu and mammals and because of the almost complete absence of repeated sequences and other junk' DNA in its genome, only essential, coding and non-coding, features are conserved. In this study, the comparative analysis of ETV6 has demonstrated conservation of the gene product across some 400 Myr of vertebrate evolution. The identi®cation of novel conserved domains and the delineation of smaller blocks of conserved residues within the ETV6 predicted proteins will provide important clues for further functional studies and target mutagenesis experiments. These analyses will be important for the understanding of angiogenesis and hematopoiesis and will give insights into the mechanism of oncogenesis by the ETV6-AML1 fusion protein, present in 25% of childhood pre-B ALL cases, in which the central section of ETV6 is always retained (reviewed in Rubnitz et al., 1999) .
